Both use the same GLP-1 hormone pathway
Semaglutide and Liraglutide: Choosing the Best Weight Loss Medication UpdatedJanuary 3, 2025 Obesity has become an escalating public health crisis in the US, with almost 70% of adults considered overweight or obese
Despite the promising results, the stock remains cheap There's hope that MariTide could be the real deal, and take away market share from other GLP-1 drugs in the future
Dropping too low risks muscle catabolism and metabolic adaptation that can slow long-term progress
Muscle mass preservation is an important consideration given the risk of sarcopenic obesity: weight loss with GLP-1 RAs includes a lean mass component (approximately 25%-40% of total weight loss), though the clinical significance in MASLD patients without sarcopenia is uncertain
The World Health Organization's When structured behavioral support addresses diet, exercise, sleep and emotional stressors that can drive abnormal weight gain, it amplifies medication efficacy, improves adherence and enhances weight loss